Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
From anemia to iron overload and infection : pathobiology of iron
Nemeth, Elizabeta; National Institutes of Health (US) Clinical Center.
[Bethesda, Md.] : [National Institutes of Health], [2022]
Treatments for anemia in chronic kidney disease : effectiveness and value : final evidence report
Mustafa, Reem A; Fox, Grace, (Of Institute for Clinical and Economic Review); Campbell, Jonathan D; Agboola, Foluso; Pearson, Steven D; Rind, David M; Bloudek, Lisa; Carlson, Josh J; Institute for Clinical and Economic Review.
[Boston, Massachusetts] : Institute for Clinical and Economic Review, March 5, 2021.
CADTH Canadian Drug Expert Committee recommendation. Iron isomaltoside 1000 (Monoferric -- pharmacosmos A/S) : indication: for the treatment of iron deficiency anemia in adult patients who have intolerance or unresponsiveness to oral iron therapy, the diagnosis must be based on laboratory tests.
CADTH Canadian Drug Expert Committee; Canadian Agency for Drugs and Technologies in Health.
Version: final. Ottawa (ON) : CADTH, March 27, 2020.
Clinical review report. Iron isomaltoside 1000 (Monoferric) (Pharmacosmos A/S) : indication: for the treatment of iron deficiency anemia in adult patients who have intolerance or unresponsiveness to oral iron therapy.
Canadian Agency for Drugs and Technologies in Health.
Final. Ottawa (ON) : CADTH, May 2020.
Pharmacoeconomic review report, Iron isomaltoside 1000 (Monoferric) (Pharmacosmos A/S) : indication: for the treatment of iron deficiency anemia in adult patients who have intolerance or unresponsiveness to oral iron therapy.
WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations.
World Health Organization.
Geneva, Switzerland : World Health Organization, [2020]
Intravenous iron preparations for patients undergoing elective surgery : a review of clinical effectiveness, cost-effectiveness, and guidelines
Banerjee, Srabani; McCormack, Suzanne, (Research information specialist); Canadian Agency for Drugs and Technologies in Health Rapid Response Service.
Version 1.0. Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health, March 27, 2019.
Screening and treatment of obstetric anemia : a review of clinical effectiveness, cost-effectiveness, and guidelines
Tran, Khai, active 2010; McCormack, Suzanne; Canadian Agency for Drugs and Technologies in Health Rapid Response Service.
Version 1.0. Ottawa : Canadian Agency for Drugs and Technologies in Health, December 6, 2019.
Nutritional anemia in preschool children
Gupta, Anil, (Child nutrition scientist).
Singapore : Springer, [2017]
Guideline. Daily iron supplementation in adult women and adolescent girls.
Geneva, Switzerland : World Health Organization, [2016]
Guideline. Iron supplementation in postpartum women
Geneva : World Health Organization, 2016.
Guideline. Use of multiple micronutrient powders for point-of-use fortification of foods consumed by pregnant women.
World Health Organization Nutrition for Health and Development.
Oral iron for anemia : a review of the clinical effectiveness, cost-effectiveness and guidelines
[Ottawa] : Canadian Agency for Drugs and Technologies in Health, 06 January 2016.
Routine iron supplementation and screening for iron deficiency anemia in pregnant women : a systematic review to update the U.S. Preventive Services Task Force recommendation
McDonagh, Marian S; Cantor, Amy; Bougatsos, Christina; Dana, Tracy; Blazina, Ian; US Preventive Services Task Force; United States Agency for Healthcare Research and Quality; Oregon Health & Science University Evidence-based Practice Center, Screening for iron deficiency anemia in childhood and pregnancy.
Rockville, MD : Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services, 2015.
Ferumoxytol versus other intravenous iron therapies for anemia : a review of the clinical and cost-effectiveness and guidelines - an update.
[Ottawa] : Canadian Agency for Drugs and Technologies in Health, 21 November 2014.
Rat︠s︡ionalʹnai︠a︡ diagnostika i lechenie zhelezodefit︠s︡itnykh sostoi︠a︡niĭ v klinike vnutrennikh bolezneĭ
Gorokhovskai︠a︡, G N.
Moskva : Izdatelʹskiĭ dom OOO "Roliks" 2014.
Biomarkers for assessing and managing iron deficiency anemia in late-Stage chronic kidney disease : identification of future research needs from Comparative effectiveness review no. 83
Chung, Mei; United States Agency for Healthcare Research and Quality; Tufts Evidence-based Practice Center; Effective Health Care Program (US).
Rockville, MD : Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services, [2013]
Detailed project report on the best practice "Use of IV iron sucrose injection for severe gestational anaemia management" : a case study with details for replication
Centre for Innovations in Public Systems (Hyderabad India); Medium Health Care Consulting (Firm).
Hyderabad : Medium Health Care Consulting, [2013?]
Assessment of iron bioavailability in humans using stable iron isotope techniques
Davidsson, L (Lena), 1957-; International Atomic Energy Agency.
Vienna : International Atomic Energy Agency, 2012.
Biomarkers for assessing and managing iron deficiency anemia in late-stage chronic kidney disease
Chung, Mei; United States Agency for Healthcare Research and Quality; Tufts Evidence-based Practice Center.
Rockville, MD : Agency for Healthcare Research and Quality, [2012]
Filters: Manage Filters